Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$335M |
| 2 |
Exelon
EXC
|
+$314M |
| 3 |
Procter & Gamble
PG
|
+$241M |
| 4 |
TripAdvisor
TRIP
|
+$208M |
| 5 |
Starbucks
SBUX
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$551M |
| 2 |
Target
TGT
|
+$514M |
| 3 |
CELG
Celgene Corp
CELG
|
+$495M |
| 4 |
Cigna
CI
|
+$369M |
| 5 |
Costco
COST
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.21% |
| 2 | Healthcare | 19.58% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Industrials | 9.29% |
| 5 | Financials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Restaurant Brands International
QSR
$28.4B
| $763K | ﹤0.01% |
11,734
+4,061
| +53% | +$250K |
|
|
IPHS
1652
DELISTED
Innophos Holdings, Inc.
IPHS
| $763K | ﹤0.01% |
25,324
-5,950
| -19% | -$179K |
|
1653
Teradyne
TER
$57B
| $761K | ﹤0.01% |
19,109
-1,547
| -7% | -$57.8K |
|
|
RP
1654
DELISTED
RealPage, Inc.
RP
| $760K | ﹤0.01% |
12,521
| – | – |
|
1655
US Physical Therapy
USPH
$1.15B
| $755K | ﹤0.01% |
7,188
+56
| +0.8% | +$6.02K |
|
1656
Travere Therapeutics
TVTX
$6.15B
| $750K | ﹤0.01% |
33,140
-3,407
| -9% | -$75.3K |
|
1657
Compañía de Minas Buenaventura
BVN
$8.94B
| $748K | ﹤0.01% |
+43,266
| New | +$707K |
|
1658
Tanger
SKT
$4.47B
| $746K | ﹤0.01% |
35,552
-1,194
| -3% | -$25.7K |
|
1659
Federal Signal
FSS
$7.31B
| $745K | ﹤0.01% |
28,660
+5,650
| +25% | +$129K |
|
1660
Monro
MNRO
$402M
| $743K | ﹤0.01% |
8,584
+1,198
| +16% | +$90.7K |
|
1661
BlackLine
BL
$1.86B
| $739K | ﹤0.01% |
15,961
-842
| -5% | -$39.6K |
|
1662
Casella Waste Systems
CWST
$6.03B
| $738K | ﹤0.01% |
20,762
-7,445
| -26% | -$243K |
|
|
SCWX
1663
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $735K | ﹤0.01% |
+39,948
| New | +$779K |
|
|
FRGI
1664
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $734K | ﹤0.01% |
55,972
+43,560
| +351% | +$644K |
|
|
DERM
1665
DELISTED
Dermira, Inc.
DERM
| $732K | ﹤0.01% |
+54,005
| New | +$450K |
|
|
TPCO
1666
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $731K | ﹤0.01% |
61,982
-40,854
| -40% | -$479K |
|
|
GES
1667
DELISTED
Guess Inc
GES
| $730K | ﹤0.01% |
37,267
+1,778
| +5% | +$37.7K |
|
1668
Monolithic Power Systems
MPWR
$63.2B
| $730K | ﹤0.01% |
5,422
+696
| +15% | +$91.3K |
|
1669
Asbury Automotive
ABG
$3.79B
| $724K | ﹤0.01% |
10,442
+1,836
| +21% | +$128K |
|
1670
Standex International
SXI
$3.67B
| $724K | ﹤0.01% |
9,864
-1,753
| -15% | -$133K |
|
1671
Cullen/Frost Bankers
CFR
$10.2B
| $720K | ﹤0.01% |
7,421
+243
| +3% | +$24.1K |
|
1672
Ironwood Pharmaceuticals
IRWD
$682M
| $719K | ﹤0.01% |
+63,484
| New | +$709K |
|
1673
MGE Energy Inc
MGEE
$3B
| $718K | ﹤0.01% |
10,568
+2,845
| +37% | +$181K |
|
1674
Huntington Bancshares
HBAN
$34.4B
| $713K | ﹤0.01% |
56,197
-119,106
| -68% | -$1.6M |
|
1675
Peapack-Gladstone Financial
PGC
$804M
| $711K | ﹤0.01% |
27,135
-5,308
| -16% | -$146K |
|
Similar funds
Cliff Asness's Q1 2019 Portfolio in Review
As of Q1 2019, Cliff Asness held 2,315 positions worth $94.3B, up 9.2% from $86.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness's Q1 2019 filing shows 140 new, 934 increased, 1,002 reduced and 155 closed positions. Its largest new stake was Canopy Growth: 121,700 shares worth $52.7M. The largest sale was Walmart Inc, an estimated $551M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Cliff Asness's largest Q1 2019 buy was Canopy Growth: 121,700 shares worth $52.7M.
- Cliff Asness added most to Biogen in Q1 2019, an estimated $335M increase.
- Cliff Asness's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $551M.
- Cliff Asness fully exited Dun & Bradstreet in Q1 2019, selling an estimated $74.4M.
- Cliff Asness's ten largest holdings make up 13% of its $94.3B portfolio in Q1 2019.
- Cliff Asness opened 140 new positions and closed 155 in Q1 2019.
- Cliff Asness's portfolio value rose 9.2% quarter-over-quarter to $94.3B.
Based on AQR Capital Management's 13F filing for Q1 2019, filed 14 May 2019.